Focus Partners Advisor Solutions LLC Invests $783,000 in The Cooper Companies, Inc. $COO

Focus Partners Advisor Solutions LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, HoldingsChannel.com reports. The fund acquired 10,925 shares of the medical device company’s stock, valued at approximately $783,000.

A number of other institutional investors also recently bought and sold shares of COO. State of Wyoming purchased a new position in Cooper Companies during the second quarter valued at $420,000. Avalon Trust Co purchased a new stake in Cooper Companies in the second quarter worth about $25,000. Bridgewater Advisors Inc. purchased a new stake in Cooper Companies in the second quarter worth about $407,000. Tema ETFs LLC raised its stake in shares of Cooper Companies by 42.4% in the second quarter. Tema ETFs LLC now owns 4,249 shares of the medical device company’s stock worth $305,000 after buying an additional 1,266 shares during the period. Finally, Handelsbanken Fonder AB raised its stake in shares of Cooper Companies by 1.1% in the second quarter. Handelsbanken Fonder AB now owns 74,834 shares of the medical device company’s stock worth $5,366,000 after buying an additional 832 shares during the period. 24.39% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on COO shares. Weiss Ratings downgraded Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Finally, Stifel Nicolaus reduced their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $81.64.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $75.10 on Tuesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The company has a market cap of $14.65 billion, a P/E ratio of 63.64, a P/E/G ratio of 1.99 and a beta of 0.83. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The firm’s fifty day moving average is $71.27 and its two-hundred day moving average is $71.22.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.